Company Filing History:
Years Active: 2000
Title: Innovator Spotlight: Mark A Collins
Introduction: Mark A Collins is a notable inventor based in Frazer, Pennsylvania, recognized for his contributions to the field of biochemistry. With a dedicated focus on innovations that impact excitatory amino acid receptors, his inventive process has led to significant advancements within the scientific community.
Latest Patents: Collins holds a patent for "1-arylphthalazine antagonists of excitatory amino acid receptors." This innovative composition comprises substituted 1-arylphthalazine formulations, showcasing his commitment to exploring new therapeutic avenues in neuropharmacology.
Career Highlights: Collins is closely affiliated with Bearsden Bio, Inc., where he applies his expertise to drive research and development forward. His work is characterized by an in-depth understanding of molecular interactions and mechanisms influencing neurotransmitter activity.
Collaborations: Collins collaborates closely with Jeffrey Claude Pelletier, leveraging their combined knowledge to enhance research outcomes. Their partnership exemplifies the spirit of teamwork essential in the innovation landscape, fostering an environment where ideas can flourish.
Conclusion: Through his patent and ongoing research, Mark A Collins is making significant strides in the field of pharmacology. His contributions not only advance scientific knowledge but also pave the way for potential therapeutic applications that could benefit many.